Anixa Biosciences Inc
Biotechnology
Healthcare
ANIX
32.05 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
2.47
52 week high
3.97
high
2.69
52 week low
2.13
previous Close
2.38
P/E ratio
market cap
83.02 M
div yield
0
net incoming
-3.28 M
-4.40 %
net profit margin
-327700000.00 %
0.00 %
operating incoming
-3.59 M
-3.61 %
net change in cash
230 K
7.00 %
cash on hand
1.23 M
23.12 %
cost of revenue
3.00 K
-75.00 %
top